Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) belong to the class of epigenetic modulators and mutations of these genes occur in up to 20% of adult AML cases [3,4,5,6] and 30% of pediatric AML [7]. This evidence concerns the gene IDH2 and acute myeloid leukemia.